Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/313616/000031361623000087/dhr-20221231.htm
September 2023
September 2023
August 2023
August 2023
August 2023
July 2023
May 2023
April 2023
January 2023
January 2023
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/313616/000031361623000087/dhr-20221231.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Danaher Corp.
Danaher Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:
Rating
Learn More![]()
Management also uses these non-GAAP financial measures to measure the Company's operating and financial performance and uses core sales growth (and previously used core sales growth including Cytiva) as one of the performance measures in the Company's executive short-term cash incentive program.
The year-over-year increase in cash used by financing activities was due primarily to net repayments of borrowings in 2022 compared to net proceeds from borrowings in 2021.
In addition, the gross profit margin was negatively impacted by a 2022 inventory charge related to reduction of business activities in Russia.
The impact of changes in currency exchange rates decreased reported sales by 4.0% on a year-over-year basis in 2022 primarily due to the unfavorable impact of the strengthening of the U.S. dollar against most other major currencies in 2022.
Year-Over-Year Changes in the Tax...Read more
Operating Profit Performance Operating profit...Read more
Operating Profit Performance Operating profit...Read more
Additionally, the declines were partially...Read more
However, the outcome of these...Read more
Operating profit margins increased 190...Read more
Operating profit margins increased 1,540...Read more
Core sales for the industrial...Read more
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT...Read more
The Company operates in a...Read more
Biotechnology Selected Financial Data Sales...Read more
These decreases were partially offset...Read more
Currency exchange rates negatively impacted...Read more
The year-over-year increase in dividend...Read more
Core sales growth (and the...Read more
The year-over-year change in operating...Read more
The Company's 2021 transaction costs...Read more
Core sales for the Company's...Read more
Diagnostics Selected Financial Data Sales...Read more
Environmental & Applied Solutions Selected...Read more
The acquisition of Aldevron on...Read more
Core sales in the pathology...Read more
Management believes that reporting these...Read more
2021 Sales Compared to 2020...Read more
2021 Sales Compared to 2020...Read more
Geographically, both high-growth and developed...Read more
Core sales for the discovery...Read more
Core sales for the discovery...Read more
Operating Profit Performance Operating profit...Read more
Operating Profit Performance Operating profit...Read more
Investments in early-stage companies have...Read more
Life Sciences Selected Financial Data...Read more
The Company recorded a pension...Read more
As of December 31, 2022,...Read more
Any weakening of the U.S....Read more
Sales Growth, Core Sales Growth...Read more
The increase was driven primarily...Read more
Costs incurred and sales recorded...Read more
In 2021, core sales for...Read more
The Company's effective tax rate...Read more
In 2021, the bioprocessing business...Read more
Year-over-year core sales in the...Read more
Core sales in developed markets...Read more
Estimates are considered to be...Read more
Investing Activities Cash flows relating...Read more
The decline was driven by...Read more
Core sales in the mass...Read more
Core sales in the mass...Read more
Amortization of intangible assets as...Read more
Amortization of intangible assets as...Read more
Interest income of $41 million...Read more
Strengthening of the U.S. dollar...Read more
Legal Proceedings Refer to Note...Read more
Danaher calculates period-to-period core sales...Read more
Geographically, the increase in core...Read more
As of December 31, 2022,...Read more
Year-over-year core sales in the...Read more
As a result, the Company...Read more
Determining whether an impairment loss...Read more
A 10% depreciation in major...Read more
Core sales in high-growth markets...Read more
The Company's continued investments in...Read more
The following factors favorably impacted...Read more
Cash and Cash Requirements As...Read more
The COVID-19 Pandemic The global...Read more
Legal Proceedings" and Notes 8...Read more
Amortization expense primarily relates to...Read more
NONOPERATING INCOME (EXPENSE) Nonoperating income...Read more
The Company funded the redemption...Read more
The Company funded the redemption...Read more
Management believes this presentation provides...Read more
Financing Activities Cash flows from...Read more
Depreciation, amortization, stock compensation and...Read more
If actual results are not...Read more
The Company continues to actively...Read more
Core sales for the industrial...Read more
Core sales in the marking...Read more
As a result of the...Read more
Core sales for the Company's...Read more
While repatriation of some cash...Read more
Core sales increased 9.5% in...Read more
The Company has deployed our...Read more
Geographically, core sales growth was...Read more
In 2022, core sales for...Read more
The segment's product identification businesses'...Read more
Acquisitions, Divestitures and Sale of...Read more
COMPREHENSIVE INCOME Comprehensive income decreased...Read more
In 2022, the average annual...Read more
The Company invests in publicly-traded...Read more
Commodity Price Risk For a...Read more
Future changes to tax rates...Read more
The Company's product identification business...Read more
During 2022, core sales in...Read more
Core sales in the molecular...Read more
Business Performance Consolidated revenues for...Read more
In addition, because most contingencies...Read more
COST OF SALES AND GROSS...Read more
Core sales in the segment's...Read more
References to sales or operating...Read more
During 2022, total segment sales...Read more
INTEREST COSTS Interest expense of...Read more
Following enactment of the TCJA...Read more
Overview of Cash Flows and...Read more
Other operating expenses and other...Read more
The proposed adjustments would increase...Read more
Since acquisition, Aldevron has seen...Read more
Net earnings for 2022 reflected...Read more
Net cash used in investing...Read more
NEW ACCOUNTING STANDARDS For a...Read more
These assumptions are forward looking...Read more
The Company has generally accepted...Read more
OPERATING EXPENSES SG&A expenses as...Read more
Impairment losses are recognized to...Read more
Core sales in the chemical...Read more
The Company's individual businesses monitor...Read more
As of December 31, 2022,...Read more
A hypothetical increase of this...Read more
On an overall basis, in...Read more
Excluding these jurisdictions, the Company...Read more
As commercial paper obligations mature,...Read more
While the ultimate resolution of...Read more
The Company's water quality business...Read more
The Company excludes the effect...Read more
These higher COVID-19 related cases...Read more
Acquired Intangibles-The Company's business acquisitions,...Read more
Core sales of the businesses'...Read more
Refer to Note 14 to...Read more
In 2021, the Company recorded...Read more
Operating cash flows from continuing...Read more
The Company is targeting to...Read more
If the Company is unsuccessful...Read more
In 2022, total Environmental &...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Danaher Corp provided additional information to their SEC Filing as exhibits
Ticker: DHR
CIK: 313616
Form Type: 10-K Annual Report
Accession Number: 0000313616-23-000087
Submitted to the SEC: Wed Feb 22 2023 4:40:48 PM EST
Accepted by the SEC: Wed Feb 22 2023
Period: Saturday, December 31, 2022
Industry: Industrial Instruments For Measurement Display And Control